Literature DB >> 35121973

Rethinking cancer clinical trials for COVID-19 and beyond.

Mehmet Goksu1, Bruno H R de Paula2, Gary J Doherty3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 35121973     DOI: 10.1038/s43018-020-0083-x

Source DB:  PubMed          Journal:  Nat Cancer        ISSN: 2662-1347


× No keyword cloud information.
  6 in total

1.  COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining.

Authors:  Aakash Desai; Vivek Subbiah
Journal:  J Immunother Precis Oncol       Date:  2020-11-16

2.  Test/Retest Reliability and Validity of Remote vs. In-Person Anthropometric and Physical Performance Assessments in Cancer Survivors and Supportive Partners.

Authors:  Teri W Hoenemeyer; William W Cole; Robert A Oster; Dorothy W Pekmezi; Andrea Pye; Wendy Demark-Wahnefried
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.575

3.  Efficacy and Sustainability of Diabetes-Specific Meal Replacement on Obese and Overweight Type-2 Diabetes Mellitus Patients: Study Approaches for a Randomised Controlled Trial and Impact of COVID-19 on Trial Progress.

Authors:  Leong Chen Lew; Arimi Fitri Mat Ludin; Suzana Shahar; Zahara Abdul Manaf; Noorlaili Mohd Tohit
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

4.  A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.

Authors:  Stella Jensen-Roberts; Taylor L Myers; Peggy Auinger; Paul Cannon; Helen M Rowbotham; Daniella Coker; Eli Chanoff; Julia Soto; Meghan Pawlik; Katherine Amodeo; Saloni Sharma; Blanca Valdovinos; Renee Wilson; Aayush Sarkar; Michael P McDermott; Roy N Alcalay; Kevin Biglan; Daniel Kinel; Caroline Tanner; Reni Winter-Evans; Erika F Augustine; Robert G Holloway; E Ray Dorsey; Ruth B Schneider
Journal:  Neurol Genet       Date:  2022-08-11

Review 5.  Virtual oncology research-different models and lessons learned.

Authors:  P Ranganathan; C S Pramesh
Journal:  Curr Opin Support Palliat Care       Date:  2022-07-22       Impact factor: 2.265

6.  The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers.

Authors:  Diviya Gupta; Shumei Kato; Razelle Kurzrock
Journal:  J Immunother Precis Oncol       Date:  2020-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.